What does Guardian Bio do?
Guardian Bio is a biotech company developing dendritic cell-based therapies designed to restore anti-tumor immune responses in cancer patients.
Explore Guardian Bio careers and hiring status. Find jobs at Guardian Bio and official application links when roles are open. Funding stage: Seed. Headcount: 1-10. Guardian Bio is a biotech company developing dendritic cell-based therapies designed to restore anti-tumor immune responses in cancer patients.
This page summarizes open roles, company profile signals, and official application paths so candidates can quickly evaluate fit before applying. Use the role list below to identify team focus, review location patterns, and jump to source listings. For broader comparison across the market, continue to the full company directory and jobs explorer.
Guardian Bio is a Seed stage AI startup, founded in 2022, with $500K in total disclosed funding. Its most recent round was a $500K Seed in Jan 2022. It has no open roles listed at the moment; new Guardian Bio openings are tracked daily. Source: Fast AI Jobs company dataset, updated Aug 2026.
Company profile last updated on Aug 18, 2026.
Guardian Bio careers and hiring status: no open roles are currently listed here, but you can review the company profile and check the official career page for the latest openings. Official careers page
Guardian Bio is an biotech company. Guardian Bio is a biotech company developing dendritic cell-based therapies designed to restore anti-tumor immune responses in cancer patients.
Open positions
Check the official career page, browse adjacent companies, or subscribe for new openings.
Candidate questions
Guardian Bio is a biotech company developing dendritic cell-based therapies designed to restore anti-tumor immune responses in cancer patients.
Guardian Bio does not have open roles listed on our platform right now. Visit the official company website or career page for the latest openings, or subscribe to get notified when new roles are posted.
Guardian Bio has raised $500K in total. The latest known stage is Seed.
Guardian Bio reports an employee count of 1-10.
Guardian Bio was founded in 2022.
Guardian Bio is associated with Biotech, Healthcare, Machine Learning, Analytics, B2B SaaS.
Company context
Guardian Bio is a Seed stage AI startup, founded in 2022, with $500K in total disclosed funding. Its most recent round was a $500K Seed in Jan 2022. It has no open roles listed at the moment; new Guardian Bio openings are tracked daily. Source: Fast AI Jobs company dataset, updated Aug 2026.